Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Swipe for next article

Independent Bulletin homepage

Download our
Social Partner

We are 8 logo (opens in a new tab)

The best jab for weight loss has been revealed following study

Weight loss jabs have been compared to see which gets the best results — Weight loss jabs have been compared to see which gets the best results (PA Wire)

A head-to-head trial showed Eli Lilly's obesity drug, Zepbound (tirzepatide), resulted in significantly greater weight loss than Novo Nordisk's Wegovy (semaglutide).
Participants on Zepbound lost an average of 50 pounds (22.8 kg) over 72 weeks, compared to 33 pounds (15 kg) for those on Wegovy.
Zepbound targets two appetite-regulating hormones, while Wegovy targets only one.
Both drugs showed improvements in health markers like blood pressure and blood sugar levels, but Zepbound had a higher rate of achieving significant weight loss (at least 25 per cent of body weight).
While most side effects were mild to moderate gastrointestinal issues, access and affordability remain a concern for both drugs.

First head-to-head trial of obesity drugs reveals best jab for weight loss — In full